Preliminary Program: Wednesday May 21
7 a.m.-8:30 a.m.
Industry-Supported Breakfast Symposia
IS42. Neuropsychiatry in the Age of Polypharmacy (Part 1) Supported by Janssen Pharmaceutica
A. An Evidence-Based Approach to Rational Polypharmacy in Schizophrenia Prakash S. Masand, M.D.
B. Polypharmacy in the Treatment of Bipolar Disorder Stuart A. Montgomery, M.D.
IS43. Treating ADHD Across the Life Cycle (Part 1) Supported by Novartis Pharmaceuticals Corporation
A. Pathophysiology of ADHD Stephen V. Faraone, Ph.D.
B. ADHD From Childhood to Adolescence: Developmental Issues in Clinical Presentations Russell A. Barkley, Ph.D.
IS44. Insomnia in Today’s Society: Consequences and Treatments (Part 1) Supported by Sanofi-Synthelabo Inc.
A. The Importance of Identifying and Treating Insomnia David N. Neubauer, M.D.
B. Pharmacotherapy of Insomnia Gregory M. Asnis, M.D.
IS45. Obesity in Psychiatric Practice: Recognition and Treatment (Part 1) Supported by Ortho-McNeil Pharmaceutical
A. Obesity Update Robert Kushner, M.D.
B. Psychotropic Medication and Weight Gain David B. Allison, Ph.D.
C. Obesity and Psychiatric Disorders Laurel Mayer, M.D.
7:30 a.m.-5 p.m.
Registration/Course Enrollment Open
8 a.m.-Noon
CME Courses 82-88
8 a.m.-5 p.m.
CME Course 89
9 a.m.-10:30 a.m.
Clinical Case Conference 3.Gia M. Crecelius, M.D., on Treating the Chronically Medically Ill Adolescent: A Case Study (Open to APA members only.)
Discussion Groups
18. Stephen C. Scheiber, M.D., on The Core Competencies: What They Mean for Residents and Faculty (Meet the Authors)
19. Anthony F. Lehman, M.D., on Evidence-Based Psychiatry: The Promise and Pitfall of Translating Science Into Practice
20. Carolyn B. Robinowitz, M.D., on Women in Leadership: Problems, Prospects, and Proposals
Lectures
L16. Title to Be Determined Prakash N. Desai, M.D., APA’s George Tarjan Award Lecture
L17. Can Psychiatry Improve Community Welfare? New Research and Practice Paradigm Kenneth B. Wells, M.D., Distinguished Psychiatrist Lecture Series
Master Educator Clinical Consultation
8. Carol C. Nadelson, M.D., on Women in Leadership: Understanding Achievement Obstacles (Open to APA members only.)
Component Workshops
CW23. Women’s Leadership 101 APA Committee on Women Co-Chairpersons: Caroline E. Fisher, M.D., Jodi E. Star, M.D.
CW24. Great Expectations: Integrating Mind and Brain in Resident Training APA/GlaxoSmithKline Fellows Co-Chairpersons: Jodi J. Gold, M.D., Rebecca Brendel, M.D.
CW25. Patient Safety in Psychiatry: Reducing Adverse Medication Events APA Task Force on Patient Safety Co-Chairpersons: Alfred Herzog, M.D., Miles F. Shore, M.D.
CW26. What Is the Ethical Stance? Issues Related to World Psychiatry and Courts APA Council on Psychiatry and Law and APA Committee on Judicial Action Chairperson: Jeffrey L. Metzner, M.D.
CW27. Teaching Competence in Psychotherapy to Residents: Are Faculty Competent? APA Committee on Psychotherapy by Psychiatrists Chairperson: Lisa A. Mellman, M.D.
CW28. Global Trauma: Experience and Implications for DSM-V APA Council on Global Psychiatry Co-Chairpersons: Arthur M. Kleinman, M.D., Harold I. Eist, M.D.
CW29. Trauma and Homelessness: Psychiatric Aspects of a Socioeconomic Problem Northern California Psychiatric Society Co-Chairpersons: Adam P. Nelson, M.D., Byron J. Wittlin, M.D.
Issue Workshops
IW64. Culture, Race, Ethnicity, and Psychopharmacology: Recent Research Advances Co-Chairpersons: Pedro Ruiz, M.D., Keh-Ming Lin, M.D.
IW65. Revision of the APA Ethics Annotations: Fostering Dialogue Chairperson: Laura W. Roberts, M.D.
IW66. The Disruptive Physician and Hospital Culture Co-Chairpersons: Glenn N. Siegel, M.D., Mary Pittman, M.S.
IW67. The Unwritten Rules for Success as a Community Psychiatrist Co-Chairpersons: Stephen M. Goldfinger, M.D., Charles W. Huffine Jr., M.D.
IW68. The Montgomery County Emergency Service Diversion Model: A Comprehensive Continuum of Forensic Interventions Chairperson: Rocio Nell, M.D.
IW69. Electronic Medical Records Enhance Quality and Productivity: The Time Has Come Chairperson: Daniel A. Deutschman, M.D.
IW70. Individual Psychotherapy With Men Suffering From Father Loss Chairperson: Lawrence L. Kennedy, M.D.
IW71. Matchmaker, Matchmaker Make Me a Match Chairperson: Lawrence Bryskin, M.D.
IW72. The Portrayal of Psychiatry in Recent American Film Chairperson: Steven E. Pflanz, M.D.
IW73. When Psychiatrists Have a Mental Illness: The Stories of Their Loved Ones National Alliance for the Mentally Ill Co-Chairpersons: Michael F. Myers, M.D., Leah J. Dickstein, M.D.
IW74. Cutting-Edge Issues in Cross-Cultural Psychiatry Chairperson: Albert C. Gaw, M.D.
IW75. The Psychiatrist’s Nightmare: A Malpractice Lawsuit Chairperson: David W. Preven, M.D.
IW76. Counseling Committed Couples: Rethinking Therapeutic Neutrality Chairperson: Scott D. Haltzman, M.D.
IW77. Intergenerational Transmission of Trauma in Prevention of Long-Term Consequences of Traumatic Stress Chairperson: Andrei Novac, M.D.
IW78. Individual Psychotherapy for Marital Problems Co-Chairpersons: Michael C. Hughes, M.D., Eva C. Ritvo, M.D.
IW79. Hepatitis C Infection: The Next Psychiatric Epidemic Chairperson: Andrew F. Angelino, M.D.
IW80. Family Therapy Training for Psychiatry Residents Chairperson: Steven J. Wolin, M.D.
IW81. Family Therapy for Anorexia Nervosa Chairperson: James D. Lock, M.D.
IW82. Helping the Healers: Providing Impairment Education to Physicians Chairperson: Karen E. Broquet, M.D.
9 a.m.-Noon
Continuous Clinical Case Conference 2. Britta Ostermeyer, M.D., Thomas G. Cobb, M.D, Renee M. Sorrentino, M.D., Steven J. Zuchowski, M.D., and Richard P. Kluft, M.D., on A Case of Murder and Dissociative Identity Disorder: Real or Malingered Mental Illness? (Part 1) (Open to APA members only.)
9 a.m.-12:30 p.m.
Review of Psychiatry (Part 3): Standardized Evaluation in Clinical Practice Chairperson: Michael B. First, M.D.
9 a.m.-4 p.m.
CME Courses 90-94
10 a.m.-3 p.m.
Exhibits Open (Last Day)
Publishers’ Bookfair Open (Last Day)
APA Resource Center Open (Last Day)
11 a.m.-12:30 p.m.
Discussion Groups
21. Robert G. Robinson, M.D., on Controversies in Vascular and Post-Stroke Depression
22. Arnold E. Andersen, M.D., on Eating Disorders in Males: A Rising Tide
23. Kathryn J. Zerbe, M.D., on Women’s Mental Health
24. Carl C. Bell, M.D., on Cross-Cultural Issues: When the Patient Is Different From You (For residents only)
Lectures
L18. The Meaning of Cognitive Impairment Marshal F. Folstein, M.D., Distinguished Psychiatrist Lecture Series
L19. Better Than Prozac: Creating New Psychiatric Drugs Samuel H. Barondes, M.D., Frontiers of Science Lecture Series
Master Educator Clinical Consultations
9. David V. Sheehan, M.D., on Anxiety Disorders (Open to APA members only.)
10. Francis G. Lu, M.D., on Cultural Assessment: The Use of the DSM-IV Outline for Cultural Formulation (Open to APA members only.)
Medical Update 3. Richard P. Brown, M.D., on Yogic Breathing: Neurophysiologic Theory and Clinical Applications for Treatment of Stress-Related Disorders, Depression, and Aggression
Research Consultation
2. Katherine L. Wisner, M.D., on Depression During Pregnancy and the Postpartum Period
Scientific and Clinical Report Sessions
Session 19. Diagnostic Issues
56. The Development of a Brief Adult Mental Health Screening Tool for Jails Robert L. Trestman, M.D.
57. Diagnosing and Treating Infants and Toddlers in Public Mental Health Settings Harry H. Wright, M.D.
58. Psychiatric Nomenclature Roger Peele, M.D.
Session 20. Biological Psychiatry and Neuroscience
59. TAK-375 Is a Highly Selective Agonist at the ML-1 Receptor Keisuke Hirai, Ph.D.
60. Safety, Pharmacokinetics, and Pharmacodynamics of TAK-375 in Healthy Adults Charlene M. Stubbs, Ph.D.
61. Selectivity of the ML-1 Agonist TAK-375: Lack of Binding to NON-ML-1 Targets Masaomi Miyamoto, Ph.D.
Session 21. Pediatric ADHD
62. An Open-Label Trial of Adderall XR: Quality-of-Life Assessments Floyd R. Sallee, M.D.
63. Long-Term Safety and Efficacy of Adderall XR in Children With ADHD Mark C. Chandler, M.D.
64. An Open-Label, Community-Assessment Trial of Adderall XR in Pediatric ADHD Paul J. Ambrosini, M.D.
Session 22. Geriatric Psychiatry
65. NIMH Atypical Antipsychotic Effectiveness Trial In Alzheimer’s CATIE-AD M. Saleem Ismail, M.D.
66. Meta-Analysis of Risperidone for Dementia: The Price Paid for Efficacy Ge A. Donker, M.D.
67. Switching Elderly Chronic Schizophrenia Patients to Olanzapine: A Prospective Study Yoram Barak, M.D.
Session 23. The Promise of Science: The Power of Healing
68. Serum Lipid Fractions in Clozapine-Treated Patients Over a Two-Year Period Charles F. Caley, Pharm.D.
69. The Influence of Group Psychoeducation on Quality of Life in Schizophrenia Patients and Their Relatives Lucie Motlova, M.D.
70. HIV-Related Stigma: Disclosure, Depression, and Social Support Rachel Power, Ph.D.
Session 24. Topics in Suicide and Violence
71. Impulsivity, Suicide, and Prefrontal Hypometabolism in Borderline Personality Paul H. Soloff, M.D.
72. Suicide Rates Over the Decade Across Civilian and Military Populations Karen M. Eaton, M.S.
73. Clozapine Reduces Violent Behavior in Heterogeneous Diagnostic Groups John E. Kraus Jr., M.D.
Session 25. Issues in Psychiatry
74. Children Excluded From Primary School: Randomized, Controlled Trial of a Team Intervention Christos Panayiotopoulos, Ph.D.
75. Malpractice Liability and Managed Care: Is a Resolution in Sight? Eugene L. Lowenkopf, M.D.
76. The Power of Humor in Psychotherapy William F. Fry Jr., M.D.
Session 26. Psychopharmacology of Headache and Anxiety Disorders
77. Clinical Experiments With Sertraline in Panic Disorder Matig R. Mavissakalian, M.D.
78. Double-Blind Oral Morphine in Treatment-Resistant OCD Lorrin M. Koran, M.D.
79. Treatment of Tension Headache With Mirtazapine Isin B. Kulaksizoglu, M.D.
Session 27. International Psychiatry
80. Excess Mortality in Schizophrenia in Stockholm County, Sweden Massimo di Giannantonio, M.D.
81. Sex Differences in Health Service Use and Functioning Associated With Depressive Symptoms: Findings From the Utrecht Health Project Mirjam I. Geerlings, Ph.D.
82. Binge Eating Disorder in Fiji, A Small-Scale, Indigenous Society Anne E. Becker, M.D.
Session 28. Cross-Cultural and Minority Issues
83. Predictors of First Depressive Episode in Black and White Women in Mid-Life Joyce T. Bromberger, Ph.D.
84. When the Poetry No Longer Rhymes: Somalis in the American Psychiatric Clinic Deborah L. Scuglik, M.D.
85. Effectiveness and Tolerability of Newer Antidepressants Among Depressed Chinese-American Patients Albert Yeung, M.D.
Component Workshops
CW30. United We Stand: Developing Partnerships for Patient Advocacy APA Committee on Public Affairs and APA Committee on Government Relations Chairperson: Mary H. Davis, M.D.
CW31. CPT Coding and Documentation Update APA Committee on RBRVS, Codes, and Reimbursements Co-Chairpersons: Chester W. Schmidt Jr., M.D., Tracy R. Gordy, M.D.
CW32. Retirement Issues for Psychiatrists and Their Spouses APA Lifers and APA Task Force on Senior Psychiatrists Chairperson: Hugh C. Hendrie, M.D.
CW33. State of the States for State Hospital Psychiatrists APA Caucus of State Hospital Psychiatrists Co-Chairpersons: Beatrice M. Kovasznay, M.D., Yadollah M. Jabbarpour, M.D.
CW34. Depressive Disorders and Hispanics: A Developmental Perspective APA Committee of Hispanic Psychiatrists Co-Chairpersons: Ana E. Campo, M.D., Oscar E. Perez, M.D.
CW35. Why Psychiatry? Says Mom APA Committee of Asian-American Psychiatrists Co-Chairpersons: John S. Luo, M.D., Surinder S. Nand, M.D.
CW36. Clinical Issues of Ethnic Diversity in Long-Term Care Facilities APA Committee on Ethnic Minority Elderly Co-Chairpersons: Ronald Brenner, M.D., Josepha A. Cheong, M.D.
CW37. Implications of Financing of Health Care for Psychiatric Education and Practice APA Council on Healthcare Systems and Financing Chairperson: Barry F. Chaitin, M.D.
CW38. Intersex Conditions: Controversies and New Approaches to Treatment APA Committee on Gay, Lesbian, and Bisexual Issues Chairperson: Richard O. Hire, M.D.
Issue Workshops
IW83. Do I Need an MBA to Transform My Career? Chairperson: Arthur L. Lazarus, M.D.
IW84. The Beginning Stages of Couples’ Therapy: Video Case Studies Chairperson: Ian E. Alger, M.D.
IW85. Healing the Hurt Child: Treating Fetal Alcohol Syndrome Spectrum Disorder Children Chairperson: Peter D. Ganime, M.D.
IW86. Going Public Over Patient Privacy Chairperson: Rodrigo A. Muñoz, M.D.
IW87. Children of Psychiatrists: Insights and Recommendations From Those Who Know Co-Chairpersons: Leah J. Dickstein, M.D., Michelle B. Riba, M.D.
IW88. International Psychiatric/Psychopharmacological Organizations’ Collaboration Supported by Collegium of International Neuropsychopharmacologicum, European College of Neuropsychopharmacology, World Federation of Societies of Biological Psychiatry, and World Psychiatric Association Chairperson: Marcia K. Goin, M.D.
Noon-1:30 p.m.
Forums
8. ABPN Update: Requirements for ABPN Examination Chairperson: Stephen C. Scheiber, M.D.
9. Meaningful Activities and Structure Matter: How a Prevocational Program Helps Severely Mentally Ill Clients Chairperson: Amelia Truman
10. APA and the Pharmaceutical Industry: Controversies and Approaches Chairperson: Stephen M. Goldfinger, M.D.
Noon-2 p.m.
New Research Poster Session 8
1 p.m.-5 p.m.
CME Courses 95-99
2 p.m.-3:30 p.m.
Lectures
L20. Title to Be Announced Donna E. Stewart, M.D., Alexandra Symonds Award Lecture of APA and Association of Women Psychiatrists
L21. Title to Be Announced, Ming T. Tsuang, M.D., APA Award for Research in Psychiatry
L22. The Revolution in Mouse Molecular Genetics: New Approaches for Psychiatric Research Laurence H. Tecott, M.D., Frontiers of Science Lecture Series
2 p.m.-5 p.m.
Symposia
S60. World Psychiatric Association’s International Guidelines for Diagnostic Assessment
A. Interviewing and Extended Sources of Information Carlos E. Berganza, M.D.
B. Evaluation of Symptoms and Mental Status Andrew E. Skodol II, M.D.
C. Standardized and Idiographic Diagnostic Formulation Juan E. Mezzich, M.D.
D. Linking Diagnosis to Treatment Ahmed Okasha, M.D.
E. A Case Formulation According to the International Guidelines for Diagnostic Assessment Miguel R. Jorge, M.D.
S61. Dimensionality in Psychiatric Disorders
A. A Diagnostic Versus a Dimensional View of Delusions: A 20-Year Follow-Up Martin Harrow, Ph.D.
B. Dimensions of Depression and Differential Sensitivity to Antidepressants Martin M. Katz, Ph.D.
C. Behavioral Dimensions of Bipolar Disorder Charles L. Bowden, M.D.
D. Dimensions of Personality Disorder Larry J. Siever, M.D.
S62. Workplace Issues in Psychotherapy APA Committee on Psychotherapy by Psychiatrists and APA Committee on APA/Business Relationships
A. Workplace Issues Are Vital in Psychotherapy Norman A. Clemens, M.D.
B. Disability and Psychotherapy Marcia A. Scott, M.D.
C. A Psychodynamic Model for Sexual and Other Forms of Workplace Harassment and Violence Stuart W. Twemlow, M.D.
D. Psychotherapy and Vocational Rehabilitation in Community Psychiatry Linda G. Gochfeld, M.D.
S63. The Nature and Treatment of BDD From Clinicians’ and Patients’ Perspectives
A. An Overview of the Phenomenology and Diagnostic Issues in BDD James Claiborn, Ph.D.
B. New Cognitive Interventions for BDD Sabine Wilhelm, Ph.D.
C. Behavioral Treatment of BDD Fugen Neziroglu, Ph.D.
D. Addiction to Plastic Surgeries in People With BDD Eda E. Gorbis, Ph.D.
E. Biological Treatment for BDD Jose A. Yaryura-Tobias, M.D.
S64. Clinical Management of Schizophrenia With Comorbid Conditions
A. Clinical Management of Depression in Schizophrenia Samuel G. Siris, M.D.
B. Management of Schizophrenia With Comorbid Anxiety Disorders Michael Y. Hwang, M.D.
C. Schizophrenia and PTSD Lewis A. Opler, M.D.
D. Persistent Aggressive Behavior in Schizophrenia: Update 2003 Leslie L. Citrome, M.D.
S65. New Research and Novel Therapeutic Strategies for OCD
A. Pharmacologic Strategies for Refractory OCD Brian A. Fallon, M.D.
B. Neurosurgical Approaches to Treatment-Intractable OCD Steven A. Rasmussen, M.D.
C. The Role of Cognitive-Behavioral Therapy in the Treatment of OCD H. Blair Simpson, M.D.
D. Effects of Cognitive Therapy for OCD Gail Steketee, Ph.D.
E. Kundalini Yoga Meditation for the Treatment of OCD David Shannahoff-Khalsa, B.S.
S66. E-Therapy, Telepsychiatry, and Virtual Environments: The Evolution of Cyberpsychiatry
A. Frontiers in Psychiatric Computerology James E. Swain, M.D.
B. Overcoming Impediments to Technological Advances in Psychiatry Norman E. Alessi, M.D.
C. Measuring Consciousness: Virtual Environments in the Assessment of Human Performance Henry J. Moller, M.D.
D. Virtual Environment for the Assessment of Attention and Memory Processes Albert A. Rizzo, Ph.D.
S67. Replenishing Ourselves: Supply of Psychiatrists for the Present and the Future
A. Current Status of the Psychiatry Workforce in the U.S. Darrel A. Regier, M.D.
B. Implications of a Need-Based Approach to Psychiatric Workforce Larry R. Faulkner, M.D.
C. Child and Adolescent Psychiatry Workforce: A Critical Shortage and National Challenge Wun-Jung Kim, M.D.
D. School by School Trends in Medical Student Career Choice of Psychiatry, 1999-2001 Frederick S. Sierles, M.D.
E. Departments of Psychiatry With High Recruitment Into Psychiatry From 1999-2001: Implication for Medical Student Education Darlene Shaw, Ph.D.
F. An Analysis of Recent Trends in Program Size, Program Type, and Demographics in Psychiatric Residency Training and Its Workforce Nyapati R. Rao, M.D.
S68. PTSD: A Latin-American Nightmare American Society of Hispanic Psychiatry (This session will be presented in Spanish only. Esta sesión será presentada en el español.)
A. Trauma and PTSD: Some New Concepts Jose M. Canive, M.D.
B. Neurobiological Findings on PTSD Gerardo Villareal, M.D.
C. Resilience: A New Concept Dora Cardona, M.D.
D. Trauma and Debriefing in the Colombian Army Daniel Toledo, M.D.
E. PTSD and PET: The Malvinas Trauma Roxana Galeno, M.D.
F. Comprehensive Management of the Patient With PTSD Renato D. Alarçon, M.D.
G. Psychopharmacology and PTSD Luis F. Ramirez, M.D.
S69. Managing Suicidality in BPD
A. Long-Term Outcome and Suicide in BPD Joel F. Paris, M.D.
B. Suicide Prediction in BPD Donald W. Black, M.D.
C. Chronic Suicidality and BPD Randy A. Sansone, M.D.
D. Liability Issues in Litigation After Suicide Thomas G. Gutheil, M.D.
E. The Application of Dialectical Behavior Therapy to Chronic Suicidality in BPD Marsha M. Linehan, Ph.D.
S70. Terrorism, War, and Refugees: Psychiatric Effects and Prevention?
A. New York City Children’s Reactions to Terrorism After 9/11 Christina Hoven, D.P.H.
B. Terrorism in Nairobi and New York: The Lessons Learned Frank G. Njenga, M.D.
C. Violence Against Civilians: A Historical Perspective Nasser F. Loza, M.B.
D. Mental Health Sequelae of the Lebanon Wars Elie G. Karam, M.D.
E. Transgenerational Transmission of Aggression Sam Tyano, M.D.
F. Not Traumatized but Demoralized: Mental Health Needs of Asylum Seekers in Britain Patrick J. Bracken, M.D.
S71. Neuropsychiatric Aspects of HIV/AIDS: An Overview (Part 1)
A. HIV Treatment Update Paul Volberding, M.D.
B. CNS Manifestations Karl Goodkin, M.D.
C. Case Discussion and Clinical Panel Warren M. Liang, M.D.
S72. Unmet Needs in Bipolar Disorder: Redefining the Spectrum and Its Boundaries
A. OCD-Bipolar Comorbidity Redefined: Place of Cyclothymia Elie G. Hantouche, M.D.
B. The Atypical Depression: Bipolar II Borderline Connection Giulio Perugi, M.D.
C. Early Recognition of Soft-Spectrum Bipolar Disorder in Children Eric A. Youngstrom, Ph.D.
D. Eating Disorders and Bipolarity: Clinical and Treatment Issues Susan L. McElroy, M.D.
E. Contrasting Early Treatment of Bipolar Disorder With the 2002 APA Guidelines Joseph R. Calabrese, M.D.
S73. Glutamate: An Exciting Neurotransmitter
A. Neuroimaging of Human Glutamatergic Systems John H. Krystal, M.D.
B. The Role of Glutamate in Psychiatric Disorders Dennis S. Charney, M.D.
C. Glutamate in Preclinical Models of Anxiety Darryle Schoepp, Ph.D.
D. The Experience With a Glutamate Agonist in GAD Jerrold F. Rosenbaum, M.D.
S74. Cognitive Dysfunction in Bipolar Disorder
A. Neuropsychological Functioning in Bipolar Disorder Eduard Vieta, M.D.
B. Psychomotor and Attentional Impairment in Bipolar Disorder Katherine E. Burdick, Ph.D.
C. Working Memory in Bipolar Disorder: Neurocognitive and Functional Imaging Findings Caleb M. Adler, M.D.
D. Differentiating Bipolar Disorder and ADHD: Comorbidity Versus Single Diagnosis Joseph Biederman, M.D.
E. Cognitive Side Effects of Mood Stabilizers Joseph F. Goldberg, M.D.
S75. Roles for Psychiatry in End-of-Life Care
A. Depression at the End-of-Life: Is That all There Is? Michael A. Weitzner, M.D.
B. Meaning-Centered Group Psychotherapy in Advanced Cancer Patients William Breitbart, M.D.
C. Complicated Grief: Conceptual Issues, Epidemiology, and Evidence-Based Clinical Implications Holly G. Prigerson, Ph.D.
D. Emotional Barriers to End-of-Life Communication: An Innovative Training for Physicians Joseph S. Weiner, M.D.
E. Oregon’s Death With Dignity Act: Who Chooses Physician-Assisted Suicide? Linda K. Ganzini, M.D.
S76. New and Practical Ways to Effectively Treat Borderline Patients
A. A Psychoeducation Program for Borderline Patients Mary C. Zanarini, Ed.D.
B. Effectiveness of Inpatient Dialectical Behavioral Therapy for BPD: A Controlled Trial Martin Bohus, M.D.
C. An Attachment-Theory-Based, Mentalization-Focused Psychotherapy for BPD: Theory and Practice Peter Fonagy, Ph.D.
D. Split Treatments: From Problem to Asset John G. Gunderson, M.D.
E. Boundaries, Liability, and Countertransference in the Treatment of BPD Glen O. Gabbard, M.D.
S77. The Dual-Diagnosis Challenge: Assessment and Treatment
A. Using the Psychiatric Research Interview for Substance and Mental Disorders to Diagnose Psychotic Disorders in Substance Users Deborah S. Hasin, Ph.D.
B. Application of the Lead Standard in Dual-Diagnosis Patients Michael B. First, M.D.
C. Differentiating Primary Versus Drug-Induced Persisting Psychosis: Biological Markers Nashaat N. Boutros, M.D.
D. Course of Substance Abuse Among Comorbid Psychotic Patients: Two-Year Follow-Up in First Admission Mark J. Sedler, M.D.
E. Peer Support for the Treatment Resistant: Will It Help? Carol L.M. Caton, Ph.D.
S78. Is This an ACT or an Act? Approaches to Assertive Community Treatment
A. Adapting the Assertive Community Treatment Model to Work With Forensic MICA Population in Supported Apartments Michelle Des Roches, M.S.W.
B. Assertive Community Treatment With Homeless Individuals Ann L. Hackman, M.D.
C. Pathways to Housing: From Streets to Homes: Housing People With Dual Diagnosis Directly From the Streets Sam Tsemberis, Ph.D.
D. Assertive Community Treatment in New York: A Platform for Implementing Evidence-Based Practices Linda Rosenberg, M.S.W.
S79. The Essence of Learning Psychiatry: Clinical Supervision
A. Models of Clinical Supervision Peter Burnett, B.M.
B. Evidence for the Efficacy: Effectiveness of Supervision in Clinical Practice Alexandra M. Cockram, M.Ed.
C. Supervision in Psychiatry Training: Current Status and Limitations Brian Kelly, B.M.
D. The Development of a Model for Training and Accrediting Supervisors David Burke
S80. Meta-Analyses of the Efficacy of Second- Versus First-Generation Antipsychotics
A. Systematic Reviews of Randomized Trials: The Example of the Atypical Antipsychotics John R. Geddes, M.R.C.
B. The Effects of Olanzapine on the Five Dimensions of Schizophrenia Derived by Factor Analysis John M. Davis, M.D.
C. Examples of How Meta-Analyses Can Inform Clinical Practice Stefan Leucht, M.D.
D. A Meta-Analysis of the Efficacy of Second-Generation Antipsychotics Ira D. Glick, M.D.
S81. The Psychological Impact of 9/11: Results From Five Major Studies
A. Findings From the National Study of Americans’ Reactions to 9/11 William E. Schlenger, Ph.D.
B. A National Longitudinal Study of Psychological Consequences of 9/11 Bradley D. Stein, M.D.
C. PTSD in New York City After 9/11 Sandro Galea, M.D.
D. Prior Tragedy Matters: Cross-Community Responses to 9/11 E. Alison Holman, Ph.D.
E. Psychosocial Predictors of Resiliency in Coping With the Tragedy of 9/11 Lisa D. Butler, Ph.D.
S82. Gay and Lesbian Parenting APA Committee on Gay, Lesbian, and Bisexual Issues
A. Children of Gay and Lesbian Parents: Confronting Myths and Stereotypes Ellen Haller, M.D.
B. Legal Issues for Gay and Lesbian Families: Protecting the Children Charles Spiegel, J.D.
C. Gay Caucasian Couples Adopting Biracial Children at Birth Brian N. Kleis, M.D.
D. New Avenues for Gay and Lesbian Parents: Fostering and International Adoptions Margery S. Sved, M.D.
E. Gay Adoption, Stepparents, and Lesbian Moms: A New American Family S. Zev Nathan, M.D.
2 p.m.-5:30 p.m.
Review of Psychiatry (Part 4): Geriatric Psychiatry Chairperson: Alan M. Mellow, M.D.
3 p.m.-5 p.m.
New Research Poster Session 9
7 p.m.-10 p.m.
Industry-Supported Symposia
IS46. Compassionate and Safe Emergent Care: Best Practices in Antipsychotic Use Supported by Janssen Pharmaceutica
A. Can Acute Care Be Compassionate? Michael H. Allen, M.D.
B. Can Acute Care Be Compassionate? Provider/Nurse’s Perspective Grad Green, M.S.N.
C. Evaluating Equivalence of Antipsychotics: Oral Versus IM Administration for Acute Disorders Glenn W. Currier, M.D.
D. Evidence-Based Medicine and the Evolving Standard of Care: Developing the Treatment Alliance Frederick Veser, M.D.
E. Transitioning Patients for Long-Term Success Robert R. Conley, M.D.
IS47. Juvenile Bipolar Disorder: Contemporary Issues in Research Supported by Novartis Pharmaceuticals Corporation
A. Diagnostic and Treatment Implications of Psychiatric Comorbidity in Juvenile Bipolar Disorder Timothy E. Wilens, M.D.
B. Pediatric Mania: A Developmental Subtype of Bipolar Disorder? Joseph Biederman, M.D.
C. The Therapeutic Role of Atypical Antipsychotic Medications in Pediatric-Onset Bipolar Disorder Janet Wozniak, M.D.
D. Treatment of Pediatric Bipolar Disorder With Anticonvulsant Mood Stabilizers Joseph M. Gonzalez-Heydrich, M.D.
E. Genetics of Early-Onset Bipolar Disorder Stephen V. Faraone, Ph.D.
IS48. Challenges in Dementia: Evidence-Based Considerations From Early Diagnosis to Long-Term Management Supported by Eisai Inc., Pfizer Inc.
A. Validated Screening Tools for Dementia John H. Greist, M.D.
B. Real World Assessment and Management of Mild Cognitive Impairment: A Case Study M. Saleem Ismail, M.D.
C. Issues and Practical Lessons in Clinical Trials in Dementia Rachelle S. Doody, M.D.
D. Cholinesterase Inhibitors in Vascular Dementia: A New Treatment Model? Stephen P. Salloway, M.D.
E. Strategies for Keeping the Brain Young Gary W. Small, M.D.
IS49. Combined Pharmacotherapy for Bipolar Disorders Supported by GlaxoSmithKline
A. The Rationale for Combined Pharmacotherapy Frederick K. Goodwin, M.D.
B. Potential Synergies in the Mechanisms of Actions of Mood Stabilizers L. Trevor Young, M.D.
C. Mood-Stabilizer Combinations: Multimodal Therapy or Polypharmacy? Terence A. Ketter, M.D.
D. Antidepressants in Combination Therapy of BPD S. Nassir Ghaemi, M.D.
E. Atypical Antipsychotics Combined With Standard Mood Stabilizers for Bipolar Disorder Joseph F. Goldberg, M.D.
IS50. Novel Therapeutic Options for Psychotic Disorders Supported by Bristol-Myers Squibb Company
A. The Evolution of Antipsychotic Therapy: A Mechanism-Based Evaluation W. Wolfgang Fleischhacker, M.D.
B. Limitations of Existing Antipsychotic Therapies Rajiv Tandon, M.D.
C. Developments in Antipsychotic Therapy: Real-World Clinical Experience Susan M. Maixner, M.D.
D. Emerging Clinical Developments in Schizophrenia and Psychotic Disorders Research Jeffrey A. Lieberman, M.D.
IS51. Bipolar Disorder: Clinical and Public Health Implications of Medical and Psychiatric Comorbidity Supported by Ortho-McNeil Pharmaceutical
A. Treatment Approaches for Managing Anxiety Disorder in the Bipolar Patient Patricia Suppes, M.D.
B. The Challenge of Treating Bipolar Disorder and Substance Abuse Mark A. Frye, M.D.
C. New Treatment Options for Eating Disorders and Obesity With Comorbid Bipolar Disorder Shishuka Malhotra, M.D.
D. Influence of Medical Comorbidities on Treatment Approaches in Bipolar Patients John L. Beyer, M.D.
E. Gender and Bipolar Disorder Lori L. Altshuler, M.D.
IS52. Striving to Heal the Mind: The Challenge of PTSD Supported by Wyeth Pharmaceuticals
A. The Global Burden of PTSD: Results From the World Health Organization International Consortium on Psychiatric Epidemiology Ronald C. Kessler, Ph.D.
B. Exposure to Stress and Trauma Across the Life Span: Neurobiological Consequences Linda L. Carpenter, M.D.
C. Early Intervention for PTSD Prophylaxis in Trauma Survivors: Emerging Evidence Arieh Y. Shalev, M.D.
D. Healing the Mind: Therapeutic Approaches for Chronic PTSD Barbara O. Rothbaum, Ph.D.
E. Medicines That Heal the Mind: Pharmacological Approaches for PTSD Jonathan R.T. Davidson, M.D. ▪
Information & Authors
Information
Published In
History
Published online: 21 February 2003
Published in print: February 21, 2003
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).